Territory Manager
Avidity
Summary
Carlsberg Britvic is the largest multi-beverage supplier in the UK and is home to some of the most iconic and popular beers & soft drinks. You'll work with leading brands such as Carlsberg Danish Pilsner, Poretti, Robinsons and products from the Pepsi portfolio.
Job description
You'll play a key role in developing relationships with retailers, growing Carlsberg Britvic market share within your defined territory, driving sales of their fantastic portfolio of beers, ciders and soft drinks by maximising brand availability and visibility in Grocery stores.
About you
- May have experience in a field sales or related role
- Excellent communicator with a professional and positive approach
- Ability to work independently or as part of a team
- Comfortable learning new digital tools
- Well organised, good planner with commercial acumen
Please note this role requires a full UK driving licence (with no more than 6 pts or previous bans), all offers will be subject to successful completion of a DVLA licence check. This is a field-based role which will involve regular travel daily so you must be comfortable driving distance. Overnights may be required on occasion.
Requirements
- May have experience in a field sales or related role
- Excellent communicator with a professional and positive approach
- Ability to work independently or as part of a team
- Comfortable learning new digital tools
- Well organised, good planner with commercial acumen
- Full UK driving licence (with no more than 6 pts or previous bans)
Benefits
- Company car
- Fuel card
- Performance bonus
- Flexible working
- Continuous coaching
- Learning and development
- Employee assistance programme
- Family working policies
- Paid holiday
- Annual leave purchase scheme
Company overview
Avidity Biosciences is a pioneering biotechnology company focused on developing a new class of RNA-targeted therapeutics called Antibody Oligonucleotide Conjugates (AOCs). The company's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide therapies to address previously undruggable targets. Avidity is advancing a pipeline of innovative treatments for serious diseases, with a primary focus on rare muscle disorders and cardiac conditions. The company's lead program targets myotonic dystrophy type 1 (DM1), a progressive genetic disorder affecting multiple organ systems. Avidity's technology platform enables targeted delivery of oligonucleotides to specific tissues and cell types, overcoming traditional delivery challenges in RNA therapeutics. The company has established strategic partnerships and collaborations to advance its research and development programs, positioning itself at the forefront of next-generation RNA-targeted medicine.